-
Pre-clinical Safety Study of LRRK2 Inhibitors
… Mol Genet 2011). The goal of this project is to further an early understanding of the safety liabilities of … and characterize any adverse findings. Relevance to Diagnosis/Treatment of Parkinson’s Disease: … MJFF Research Grant … Research Staff of The Michael J. Fox Foundation …
-
Associate Director, Research Operations
… Now About Us: The Michael J. Fox Foundation for Parkinson’s Research (MJFF) was founded in 2000 with one clear … organization. Since inception, MJFF has quickly grown into the largest nonprofit funder of Parkinson’s disease research, having funded over $1.5 billion in research …
-
Measuring Alpha-synuclein in Extracellular Vesicles: A Biomarker for the Diagnosis and Staging of Neuronal α-Synuclein Diseases
… would provide a more accessible tool for disease diagnosis and could facilitate the evaluation of disease … propose is based on nanosized vesicles released by neurons into the bloodstream, called neuron-derived extracellular … individuals for clinical trials, particularly in the early stages of disease, when symptoms are not clear. The …
-
Applying Artificial Intelligence for Early Identification of Parkinson’s Disease
… (AI) applied to EKGs can help identify people in very early stages of PD, before they show other classic signs of … Healthcare System in Memphis, Tennessee. Impact on Diagnosis/Treatment of Parkinson’s disease: If successful, … PD. If successful, we hope to make this model available to researchers for ongoing and future clinical trials. …
-
From Diagnosis to IRONMAN 70.3, One Team Fox Member Learns to Raise the Bar
June 17, 2014
… Every day I'm challenged with something new. In the early stages of training I had to deal with a number of …
-
Parkinson's Protein Levels Stable over Year in Early Disease
October 13, 2017
… Today researchers from the Parkinson's Progression Markers … cohort: people with Parkinson's risk factors but not diagnosis. And I put a lot of hope in more specific …